New Atlas34m
Alzheimer’s drug trial raises concerns for accelerating cognitive decline
While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...
ProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease Conference
Results indicated PMN310 was generally well-tolerated and monthly dosing can provide CSF levels adequate for target ...
The Brighterside of News on MSN2h
Natural dietary supplement can successfully treat Alzheimer's disease
This increase correlated with changes in biomarkers associated with neurodegenerative diseases like Alzheimer’s, such as ...
Korea University Guro Hospital 'Alzheimer's Prevention Center' Provides customized treatment for each open patient
Korea University Guro Hospital has opened the Alzheimer's Prevention Center (Center Director Kang Sung-hoon).The Alzheimer's ...
Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality
NEWTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the ...